Search
Milestone Pharmaceuticals Inc
MISTAdd to Watchlist
1.140USD
-0.020-1.72%
Close 09-01 16:00（ET）
141.93MMarket Cap
LossP/E TTM
More Details of Milestone Pharmaceuticals Inc Company
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Milestone Pharmaceuticals Inc Profile
Ticker SymbolMIST
Company nameMilestone Pharmaceuticals Inc
IPO dateMay 09, 2019
CEOOliveto (Joseph)
Number of employees33
Security typeOrdinary Share
Fiscal year-endMay 09
Address420-1111 boul. Dr.-Frederik-Philips
CityMONTREAL
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeH4M 2X6
Phone15143360444
Websitehttps://www.milestonepharma.com
Ticker SymbolMIST
IPO dateMay 09, 2019
CEOOliveto (Joseph)
Company Executives of Milestone Pharmaceuticals Inc
Name
Name/Position
Position
Shareholding
Change
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
+0.01%
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
Mr. Lorenz Muller
Mr. Lorenz Muller
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Seth H. Z. Fischer
Mr. Seth H. Z. Fischer
Independent Director
Independent Director
--
--
Mr. Jeffrey Nelson
Mr. Jeffrey Nelson
Chief Operating Officer
Chief Operating Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
+0.01%
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
FAQs
Who are the top five shareholders of Milestone Pharmaceuticals Inc?
The top five shareholders of Milestone Pharmaceuticals Inc are: Dr. David Bharucha
How many institutions hold shares of Milestone Pharmaceuticals Inc (MIST)?
As of 2026Q1, 133 institutions hold shares of Milestone Pharmaceuticals Inc, with a combined market value of approximately 30.89M, accounting for 25.86% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -18702702.00.